This report delves into the intricate journey of Israel’s cannabis sector, tracing its roots from groundbreaking research in the 1960s, to its current status as a global leader in the medical cannabis industry.
The report provides insight on (but is not limited to):
Regulatory Reform: A set of reforms planned this year will see a transformation in Israel’s medical cannabis environment.
Patient Access: With over 137,000 medical cannabis patients, Israel has the highest rate per capita of any country in the world – with significant patient population growth anticipated in the next few years.
Competitor & Product Landscape: An overview of the cannabis ecosystem in Israel, leading players and available medical cannabis products.
Future Outlook: Israel’s Ministry of Health has led a transformative journey to overhaul the country’s mandatory healthcare system. What are the next steps?
